Rx Medicare

B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it anticipates U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun’s DUPLEX(R) Drug Delivery System. The FDA approval will make B. Braun the first company to deliver an FDA approved 2g Cefazolin dose to hospitals and other healthcare settings where it is a frequently prescribed antibiotic.

Read More…

Related Posts

• Forensic Laboratories Develops First Oral Fluid Test For Tapentadol
• First Results In United States In 20 Years From Clinical Trials Of Smoked Cannabis
• Fibromyalgia: Drugs Approved by the FDA to Manage Pain
• UGL Unicco First To Embrace Ionator EXP Ionized Water Cleaner That Kills H1N1 Virus
• High Dose Seasonal Influenza Vaccine Specifically Intended For People Ages 65 And Older Approved By U.S. FDA
• First effective medical therapy for rare stomach disorder
• 62-Year-Old Man Becomes First Patient In China Implanted With Rechargeable Neurostimulator For Chronic Pain
• H1N1 Flu Virus: First Virtual Summit For First Nations Communities A Success, Canada
• Assembly Of First Nations And Health Canada To Co-host A Virtual Summit On H1N1 Preparedness November 10th, 2009
• Government Of Canada And Cowessess First Nation Highlight Cooperation On Pandemic Planning And Preparedness
• Houston Northwest Medical Center Becomes The First And Only Hospital In Houston To Receive Prestigious Cycle III Chest Pain Center Accreditation
• Breakthrough Cancer Pain: First Results From Major European Patient Survey
• With Summer Jobs, Med Students Experience Health System Challenges First Hand
• MisterSterile.com Launch The World’s First Dry-On-Contact H1N1 Sanitising Spray, UK
• Pandemic Vaccine Priority For Most At Risk – More Than 11 Million People In England Will Be Targeted First

Tags: anticipates, approved, becoming, braun, cefazolin, deliver, first

This entry was posted on Friday, June 5th, 2009 at 7:06 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.